Volumen 3, Ausgabe 1 (2013)
Clinical-Trail-Methode
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
Klinischer Trail-Prospekt
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Rückblick: Ergebnisse klinischer Studien
Targeted therapy for hepatocellular carcinoma: current status and future direction
Stephen L Chan, Tony Mok
Clinical-Trail-Methode
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Rückblick: Ergebnisse klinischer Studien
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Forschungsupdate
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Methodik
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
